1999
DOI: 10.1002/(sici)1098-1004(1999)13:4<280::aid-humu3>3.0.co;2-l
|View full text |Cite
|
Sign up to set email alerts
|

Mutations of the humanBTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia

Abstract: X‐linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the gene coding for Bruton agammaglobulinemia tyrosine kinase (BTK). A database (BTKbase) of BTK mutations lists 544 mutation entries from 471 unrelated families showing 341 unique molecular events. In addition to mutations, a number of variants or polymorphisms have been found. Mutations in all the five domains of BTK cause the disease, the single most common event being missense mutations. Most mutations lead to truncation of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
59
0
4

Year Published

2000
2000
2008
2008

Publication Types

Select...
8
1
1

Relationship

4
6

Authors

Journals

citations
Cited by 105 publications
(68 citation statements)
references
References 33 publications
3
59
0
4
Order By: Relevance
“…[Vihinen et al, 1994a[Vihinen et al, ,b, 1995[Vihinen et al, , 1997[Vihinen et al, , 1999), SH2 domain protein 1A (SH2D1A) mutations in X-linked lymphoproliferative disease [Lappalainen et al, 2000], Bloom syndrome protein (BLM) mutations in Bloom syndrome , mutations in the Wiscott-Aldrich syndrome protein (WAS) protein in Wiskott-Aldrich syndrome , mutations in the methyltransferase (DNMT3B) in immunodeficiency, centromeric instability, and facial abnormalities (ICF) syndrome [Lappalainen and Vihinen, 2002], and CD40L mutations in X-linked hyperimmunoglobulin M (hyper-IgM) syndrome (Thusberg, J., and Vihinen, M., unpublished results). We utilize experience gained in all these studies to discuss the effects of mutations and also the use and applicability of different methods.…”
Section: Discussionmentioning
confidence: 99%
“…[Vihinen et al, 1994a[Vihinen et al, ,b, 1995[Vihinen et al, , 1997[Vihinen et al, , 1999), SH2 domain protein 1A (SH2D1A) mutations in X-linked lymphoproliferative disease [Lappalainen et al, 2000], Bloom syndrome protein (BLM) mutations in Bloom syndrome , mutations in the Wiscott-Aldrich syndrome protein (WAS) protein in Wiskott-Aldrich syndrome , mutations in the methyltransferase (DNMT3B) in immunodeficiency, centromeric instability, and facial abnormalities (ICF) syndrome [Lappalainen and Vihinen, 2002], and CD40L mutations in X-linked hyperimmunoglobulin M (hyper-IgM) syndrome (Thusberg, J., and Vihinen, M., unpublished results). We utilize experience gained in all these studies to discuss the effects of mutations and also the use and applicability of different methods.…”
Section: Discussionmentioning
confidence: 99%
“…Btk is the only member of the Tec family kinases in which mutations have been found to be associated with a disease (7,47,48). Intriguingly, point mutations of the highly conserved aromatic residues in the caveolin-binding motif within the catalytic domain of Btk have been detected in patients with classical XLA (Table I) (7).…”
Section: Discussionmentioning
confidence: 99%
“…Mutations in the SH2 domain of Btk are associated with impaired B cell function and may cause the XLA immunode®ciency in humans, possibly due to disruption of phosphotyrosine binding sites (Vihinen et al, 1999). Several proteins have been shown to interact with the SH2 domains of Btk kinases and to modulate their functions.…”
Section: Sh2 Domainmentioning
confidence: 99%